NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight

Go back to NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
(NASDAQ: ELAB) Delayed: 4.85 -0.36 (6.91%)
Previous Close $5.21    52 Week High
Open $5.21    52 Week Low
Day High $5.35    P/E N/A 
Day Low $4.82    EPS
Volume 30,180       

(NASDAQ: ELAB) Delayed: 4.85 -0.36 (6.91%)
Previous Close $5.21    52 Week High
Open $5.21    52 Week Low
Day High $5.35    P/E N/A 
Day Low $4.82    EPS
Volume 30,180